Publications To Date

    NANOSTRING PUBLICATIONS

    Filter Publications

    PAGE 11 OF 87 | DISPLAYING 151 - 165 OF 1293 RESULTS

    Kaur G et al., Minichromosome Maintenance Complex (MCM) Genes Profiling and MCM2 Protein Expression in Cervical Cancer Development., , Asian Pac J Cancer Prev, Oct 01, 2019

    Lee O et al., Selective Progesterone Receptor Modulators in Early-Stage Breast Cancer: A Randomized, Placebo-Controlled Phase II Window-of-Opportunity Trial Using Telapristone Acetate., , Clin Cancer Res, Sep 30, 2019

    Dong J et al., Nanostructured Substrates for Detection and Characterization of Circulating Rare Cells: From Materials Research to Clinical Applications., , Adv Mater, Sep 30, 2019

    Halse H et al., A distinct pre-treatment immune gene signature in lentigo maligna is associated with imiquimod response, , J Invest Dermatol., Sep 30, 2019

    Flesher JL et al., Delineating the role of MITF isoforms in pigmentation and tissue homeostasis, , Pigment Cell Melanoma Res., Sep 28, 2019

    López‐Sánchez LM et al., SWATH‐based proteomics reveals processes associated with immune evasion and metastasis in poor prognosis colorectal tumours., , J Cell Mol Med, Sep 27, 2019

    Lorent J et al., Translational offsetting as a mode of estrogen receptor α‐dependent regulation of gene expression, , EMBO J, Sep 26, 2019

    Guerreiro Stucklin AS et al., Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas., , Nat Commun, Sep 25, 2019

    Leal FM et al., Early Enrichment of ESR1 Mutations and the Impact on Gene Expression in Presurgical Primary Breast Cancer Treated with Aromatase Inhibitors, , Clin Cancer Res, Sep 23, 2019

    Nixon MJ et al., PIK3CA and MAP3K1 alterations imply luminal A status and are associated with clinical benefit from pan-PI3K inhibitor buparlisib and letrozole in ER+ metastatic breast cancer., , NPJ Breast Cancer, Sep 23, 2019

    Caetano MS et al., Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses., , Clin Cancer Res, Sep 20, 2019

    Robinson MH et al., Upregulation of the chromatin remodeler HELLS is mediated by YAP1 in Sonic Hedgehog Medulloblastoma., , Sci Rep, Sep 20, 2019

    Schreiber LM et al., The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer., , Br J Cancer, Sep 18, 2019

    Ronsley R et al., The TLR9 agonist (GNKG168) induces a unique immune activation pattern in vivo in children with minimal residual disease positive acute leukemia: Results of the TACL T2009-008 phase I study., , Pediatr Hematol Oncol, Sep 18, 2019

    Adamo B et al., Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial., , Breast Cancer Res, Sep 18, 2019